Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer
Kai Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Suet Yi Leung(Tuen Mun Hospital), Anthony K W Chan(Queen Mary Hospital), Jiangchun Xu(Pfizer (United States)), Siu Po Lee(Queen Mary Hospital), Peter Roberts(Pfizer (United States)), Simon Law(Inserm), Zhengyan Kan(Pfizer (United States)), David Pocalyko(Pfizer (United States)), Stephanie T. Shi(Pfizer (United States)), Grace H.W. Cheng(Queen Mary Hospital), Paul A. Rejto(Pfizer (United States)), Tsun Leung Chan(University of Hong Kong), Siu Lun Ho(Queen Mary Hospital), Wai Yin Tsui(Queen Mary Hospital), Siu Tsan Yuen(Queen Mary Hospital), Annie S.Y. Chan(Queen Mary Hospital), Neil W. Gibson(Regulus Therapeutics (United States)), Junsuo Kan(Queen Mary Hospital), Mao Mao(Pfizer (United States)), Kent‐Man Chu(Chinese University of Hong Kong)
Cited by 775
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma
|JAMA|2008|1.6k
Helicobacter pylori Eradication to Prevent Gastric Cancer in a High-Risk Region of China
|JAMA|2004|1.4k